TTNP - Titan Pharmaceuticals, Inc. (de)
IEX Last Trade
5.97
0.307 5.134%
Share volume: 148,836
Last Updated: Fri 30 Aug 2024 05:46:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$5.66
0.31
5.41%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
| Report Date | 2022-05-16 | 2022-08-11 | 2022-11-14 | 2023-03-31 | 2023-05-15 | |
| Total revenue | 192.000 K | 150.000 K | 95.000 K | 120.000 K | 98.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 192.000 K | 150.000 K | 95.000 K | 120.000 K | 98.000 K | |
| -21.88% | -36.67% | 26.32% | -18.33% | |||
| Operating expenses | 2.731 M | 2.592 M | 2.738 M | 2.731 M | 1.795 M | |
| Selling general and admin | 1.322 M | 1.618 M | 1.806 M | 1.288 M | 1.234 M | |
| Research and development | 1.409 M | 974.000 K | 932.000 K | 1.443 M | 561.000 K | |
| Total expenses | 2.731 M | 2.592 M | 2.738 M | 2.731 M | 1.795 M | |
| -5.09% | 5.63% | -0.26% | -34.27% | |||
| Operating income | -2.539 M | -2.442 M | -2.643 M | -2.611 M | -1.697 M | |
| Ebit | -2.539 M | -2.442 M | -2.643 M | -2.611 M | -1.697 M | |
| Pretax income | -2.540 M | -2.462 M | -2.638 M | -2.566 M | -1.675 M | |
| -3.07% | 7.15% | -2.73% | -34.72% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -2.540 M | -2.462 M | -2.638 M | -2.566 M | -1.675 M | |
| 3.07% | -7.15% | 2.73% | 34.72% | |||
| Net income | -2.540 M | -2.462 M | -2.638 M | -2.566 M | -1.675 M | |
| 3.07% | -7.15% | 2.73% | 34.72% |